2144. Performance of 2019 CLSI Ciprofloxacin Breakpoint Antimicrobial Susceptibility Testing Algorithms for Enterobacteriaceae and Pseudomonas aeruginosa Directly from Positive Blood Culture on the Accelerate Pheno™ System

BACKGROUND: The Clinical and Laboratory Standards Institute (CLSI) updated fluoroquinolone breakpoints in 2019 in response to evolving resistance and new outcome data. The performance of updated antimicrobial susceptibility testing (AST) algorithms for ciprofloxacin with the 2019 breakpoints for Ent...

Descripción completa

Detalles Bibliográficos
Autores principales: Shamsheyeva, Alena, Oppermann, Niels, Taku, Aimee, Ndobegang, Anyangatia, Gamage, Dulini, Chantell, Christina, Humphries, Romney
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6809880/
http://dx.doi.org/10.1093/ofid/ofz360.1824

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6809880/
http://dx.doi.org/10.1093/ofid/ofz360.1824

Ejemplares similares